| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Jan 14, 2026 | Aktis Oncology, Inc. | 10% Owner | Buy | 100.0 | +1,112,777 | 12.17% | ✗ | $20M |
| Dec 10, 2024 | Dec 12, 2024 | Entrada Therapeutics, Inc. | 10% Owner | Sell | 20.0 | -44,722 | -1.01% | ✗ | $917.1K |
| Nov 2, 2021 | Nov 4, 2021 | Entrada Therapeutics, Inc. | 10% Owner | Buy | 87.5 | +100,000 | 2.31% | ✗ | $2M |